Allergy Therapeutics’ peanut allergy vax encouraging action in animal model

UK-based Allergy Therapeutics (OTCPK:AGYTF) announces the publication of positive data on its peanut allergy vaccine candidate in The Journal of Allergy and Clinical Immunology.

Results from a peanut allergy mouse model showed that the novel virus-like particle platform used in the vaccine candidate could treat the allergies and prevent anaphylaxis based on a single injection.

Peanut allergy-related tickers: Aimmune Therapeutics (NASDAQ:AIMT), DBV Technologies (NASDAQ:DBVT)

https://seekingalpha.com/news/3535635-allergy-therapeutics-peanut-allergy-vaccine-shows-encouraging-action-in-animal-model